Osteoporosis is a known consequence of stroke, associated with an increased incidence of fractures, mainly of the hip, leading to further disability. The pattern of bone loss seen in stroke patients is different from that usually encountered with postmenopausal osteoporosis, since it is limited to the paretic side and more evident in the upper extremities. Several factors appear to have an influence on bone mass in stroke patients, such as the degree of paresis, gait disability and the duration of immobilization. The pathogenesis of osteoporosis after stroke remains unclear. Paresis, reduced mobility and reduced bone load seem to play a major role. Other factors such as nutritional and iatrogenic ones may also play an important part. In this paper, the clinical evidence, pathophysiology and possible treatments of poststroke osteoporosis will be reviewed.

Keywords:
Bone mineral density, Osteoporosis, Stroke, Hemiplegia
1.
Worthen LC, Kim CM, Kautz SA, Lew HL, Kiratli BJ, Beaupre GS: Key characteristics of walking correlate with bone density in individuals with chronic stroke. J Rehabil Res Dev 2005;42:761–768.
2.
del Puente A, Pappone N, Mandes MG, Mantova D, Scarpa R, Oriente P: Determinants of bone mineral density in immobilization: a study on hemiplegic patients. Osteoporos Int 1996;6:50–54.
3.
Hamdy RC, Moore SW, Cancellaro VA, Harvill LM: Long-term effects of strokes on bone mass. Am J Phys Med Rehabil 1995;74:351–356.
4.
Levendoglu F, Ugurlu H, Gürbilek M, Akkurt E, Karagözoglu E: Increased bone resorption in the proximal femur in patients with hemiplegia. Am J Phys Med Rehabil 2004;83:835–841.
5.
Pang MY, Eng JJ, McKay HA, Dawson AS: Reduced hip bone mineral density is related to physical fitness and leg lean mass in ambulatory individuals with chronic stroke. Osteoporos Int 2005;16:1769–1779.
6.
Takamoto S, Masuyama T, Nakajima M, Seikiya K, Kosaka H, Morimoto S, et al: Alterations of bone mineral density of the femurs in hemiplegia. Calcif Tissue Int 1995;56:259–262.
7.
Dennis MS, Lo KM, McDowall M, West T: Fractures after stroke: frequency, types, and associations. Stroke 2002;33:728–734.
8.
Ramnemark A, Nyberg L, Borssen B, Olsson T, Gustafson Y: Fractures after stroke. Osteoporos Int 1998;8:92–95.
9.
Ramnemark A, Nilsson M, Borssen B, Gustafson Y: Stroke, a major and increasing risk factor for femoral neck fracture. Stroke 2000;31:1572–1577.
10.
Hodkinson HM, Brain AT: Unilateral osteoporosis in longstanding hemiplegia in the elderly. J Am Geriatr Soc 1967;15:59–64.
11.
Wing H, Leavitt LA: Complications of hemiplegia in cerebrovascular disease. South Med J 1961;54:606–609.
12.
Hamdy RC, Krishnaswamy G, Cancellaro V, Whalen K, Harvill L: Changes in bone mineral content and density after stroke. Am J Phys Med Rehabil 1993;72:188–191.
13.
Jorgensen L, Crabtree NJ, Reeve J, Jacobsen BK: Ambulatory level and asymmetrical weight bearing after stroke affects bone loss in the upper and lower part of the femoral neck differently: bone adaptation after decreased mechanical loading. Bone 2000;27:701–707.
14.
Jorgensen L, Jacobsen BK, Wilsgaard T, Magnus JH: Walking after stroke: does it matter? Changes in bone mineral density within the first 12 months after stroke: a longitudinal study. Osteoporos Int 2000;11:381–387.
15.
Lazoura O, Groumas N, Antoniadou E, Papadaki PJ, Papadimitriou A, Thriskos P, et al: Bone mineral density alterations in upper and lower extremities 12 months after stroke measured by peripheral quantitative computed tomography and DXA. J Clin Densitom 2008;11:511–517.
16.
Prince RL, Price RI, Ho S: Forearm bone loss in hemiplegia: a model for the study of immobilization osteoporosis. J Bone Miner Res 1988;3:305–310.
17.
Ramnemark A, Nyberg L, Lorentzon R, Englund U, Gustafson Y: Progressive hemiosteoporosis on the paretic side and increased bone mineral density in the nonparetic arm the first year after severe stroke. Osteoporos Int 1999;9:269–275.
18.
Sato Y, Maruoka H, Honda Y, Asoh T, Fujimatsu Y, Oizumi K: Development of osteopenia in the hemiplegic finger in patients with stroke. Eur Neurol 1996;36:278–283.
19.
Yavuzer G, Ataman S, Suldur N, Atay M: Bone mineral density in patients with stroke. Int J Rehabil Res 2002;25:235–239.
20.
Sato Y, Kuno H, Kaji M, Ohshima Y, Asoh T, Oizumi K: Increased bone resorption during the first year after stroke. Stroke 1998;29:1373–1377.
21.
Frotzler A, Berger M, Knecht H, Eser P: Bone steady-state is established at reduced bone strength after spinal cord injury: a longitudinal study using peripheral quantitative computed tomography (pQCT). Bone 2008;43:549–555.
22.
Sato Y, Fujimatsu Y, Kikuyama M, Kaji M, Oizumi K: Influence of immobilization on bone mass and bone metabolism in hemiplegic elderly patients with a long-standing stroke. J Neurol Sci 1998;156:205–210.
23.
Kumar V, Kalita J, Gujral RB, et al: A study of bone densitometry in patients with complex regional pain syndrome after stroke. Postgrad Med J 2001;77:519–522.
24.
Pang MY, Eng JJ: Muscle strength is a determinant of bone mineral content in the hemiparetic upper extremity: implications for stroke rehabilitation. Bone 2005;37:103–111.
25.
Sahin L, Ozoran K, Gunduz OH, Ucan H, Yucel M: Bone mineral density in patients with stroke. Am J Phys Med Rehabil 2001;80:592–596.
26.
Sato Y, Asoh T, Kondo I, Satoh K: Vitamin D deficiency and risk of hip fractures among disabled elderly stroke patients. Stroke 2001;32:1673–1677.
27.
Watanabe Y: An assessment of osteoporosis in stroke patients on rehabilitation admission. Int J Rehabil Res 2004;27:163–166.
28.
Whitson HE, Pieper CF, Sanders L, Horner RD, Duncan PW, Lyles KW: Adding injury to insult: fracture risk after stroke in veterans. J Am Geriatr Soc 2006;54:1082–1088.
29.
Jorgensen L, Jacobsen BK: Changes in muscle mass, fat mass, and bone mineral content in the legs after stroke: a 1 year prospective study. Bone 2001;28:655–659.
30.
Jorgensen L, Jacobsen BK: Functional status of the paretic arm affects the loss of bone mineral in the proximal humerus after stroke: a 1-year prospective study. Calcif Tissue Int 2001;68:11–15.
31.
Ramnemark A, Nyberg L, Lorentzon R, Olsson T, Gustafson Y: Hemiosteoporosis after severe stroke, independent of changes in body composition and weight. Stroke 1999;30:755–760.
32.
Ikai T, Uematsu M, Eun SS, Kimura C, Hasegawa C, Miyano S: Prevention of secondary osteoporosis postmenopause in hemiplegia. Am J Phys Med Rehabil 2001;80:169–174.
33.
Liu M, Tsuji T, Higuchi Y, Domen K, Tsujiuchi K, Chino N: Osteoporosis in hemiplegic stroke patients as studied with dual-energy X-ray absorptiometry. Arch Phys Med Rehabil 1999;80:1219–1226.
34.
Poole KE, Warburton EA, Reeve J: Rapid long-term bone loss following stroke in a man with osteoporosis and atherosclerosis. Osteoporos Int 2005;16:302–305.
35.
Iversen E, Hassager C, Christiansen C: The effect of hemiplegia on bone mass and soft tissue body composition. Acta Neurol Scand 1989;79:155–159.
36.
Bainbridge NJ, Davie MW, Haddaway MJ: Bone loss after stroke over 52 weeks at os calcis: influence of sex, mobility and relation to bone density at other sites. Age Ageing 2006;35:127–132.
37.
Iwamoto J, Tsukimura T, Takeda T: Bone mineral density of metatarsus in hemiplegic subjects. Am J Phys Med Rehabil 1999;78:202–207.
38.
National Osteoporosis Foundation (NOF): Clinician’s guide to prevention and treatment of osteoporosis. 2008. http://www.nof.org/professionals/NOF_Clinicians_Guide.pdf (accessed February 12, 2009).
39.
Brown DL, Morgenstern LB, Majersik JJ, Kleerekoper M, Lisabeth LD: Risk of fractures after stroke. Cerebrovasc Dis 2008;25:95–99.
40.
Kanis J, Oden A, Johnell O: Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke 2001;32:702–706.
41.
Grisso JA, Kelsey JL, Strom BL, Chiu GY, Maislin G, O’Brien LA, et al: Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991;324:1326–1331.
42.
Jorgensen L, Engstad T, Jacobsen BK: Higher incidence of falls in long-term stroke survivors than in population controls: depressive symptoms predict falls after stroke. Stroke 2002;33:542–547.
43.
Forster A, Young J: Incidence and consequences of falls due to stroke: a systematic inquiry. BMJ 1995;311:83–86.
44.
Chiu KY, Pun WK, Luk KD, Chow SP: A prospective study on hip fractures in patients with previous cerebrovascular accidents. Injury 1992;23:297–299.
45.
Minaire P: Immobilization osteoporosis: a review. Clin Rheumatol 1989;8(suppl 2):95–103.
46.
Stewart AF, Adler M, Byers CM, Segre GV, Broadus AE: Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. N Engl J Med 1982;306:1136–1140.
47.
Sato Y, Oizumi K, Kuno H, Kaji M: Effect of immobilization upon renal synthesis of 1,25-dihydroxyvitamin D in disabled elderly stroke patients. Bone 1999;24:271–275.
48.
Sato Y, Kuno H, Asoh T, Honda Y, Oizumi K: Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients. Age Ageing 1999;28:265–269.
49.
Pang MY, Ashe MC, Eng JJ: Muscle weakness, spasticity and disuse contribute to demineralization and geometric changes in the radius following chronic stroke. Osteoporos Int 2007;18:1243–1252.
50.
Pang MY, Ashe MC, Eng JJ: Tibial bone geometry in chronic stroke patients: influence of sex, cardiovascular health, and muscle mass. J Bone Miner Res 2008;23:1023–1030.
51.
Baer G, Smith M: The recovery of walking ability and subclassification of stroke. Physiother Res Int 2001;6:135–144.
52.
Holick MF: Vitamin D deficiency. N Engl J Med 2007;357:266–281.
53.
Shinchuk LM, Morse L, Huancahuari N, Arum S, Chen TC, Holick MF: Vitamin D deficiency and osteoporosis in rehabilitation inpatients. Arch Phys Med Rehabil 2006;87:904–908.
54.
Kim HW, Kang E, Im S, Ko YJ, Im SA, Lee JI: Prevalence of pre-stroke low bone mineral density and vertebral fracture in first stroke patients. Bone 2008;43:183–186.
55.
Kuno H: Vitamin D status and nonhemiplegic bone mass in patients following stroke. Kurume Med J 1998;45:257–263.
56.
Sato Y, Maruoka H, Oizumi K, Kikuyama M: Vitamin D deficiency and osteopenia in the hemiplegic limbs of stroke patients. Stroke 1996;27:2183–2187.
57.
Sato Y, Metoki N, Iwamoto J, Satoh K: Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in stroke patients. Neurology 2003;61:338–342.
58.
Fujimatsu Y: Role of parathyroid gland on bone mass and metabolism in immobilized stroke patients. Kurume Med J 1998;45:265–270.
59.
Shearer MJ: Vitamin K. Lancet 1995;345:229–234.
60.
Vermeer C, Jie KSG, Knapen MHJ: Role of vitamin K in bone metabolism. Annu Rev Nutr 1995;15:1–22.
61.
Szulc P, Arlot M, Chapuy MC, Meunier PJ, Delmas PD: Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res 1994;9:1591–1595.
62.
Sato Y, Kuno H, Kaji M, Saruwatari N, Oizumi K: Effect of ipriflavone on bone in elderly hemiplegic stroke patients with hypovitaminosis D. Am J Phys Med Rehabil 1999;78:457–463.
63.
van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, van der Klift M, de Jonge R, Lindemans J: Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033–2041.
64.
Sato Y, Honda H, Iwamoto J, Kanoko T, Satoh K: Effect of folate and mecobalamin on hip fractures in patients with stroke. JAMA 2005;293:1082–1088.
65.
Sato Y, Honda Y, Kunoh H, Oizumi K: Long-term oral anticoagulation reduces bone mass in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation. Stroke 1997;28:2390–2394.
66.
Cheng HY: The association of warfarin use with osteoporotic fracture in elderly patients with atrial fibrillation. Arch Intern Med 2006;166:1525, author reply 1525.
67.
Philip WJ, Martin JC, Richardson JM, Reid DM, Webster J, Douglas AS: Decreased axial and peripheral bone density in patients taking long-term warfarin. Q J Med 1995;88:635–640.
68.
Andress DL, Ozuna J, Tirschwell D, Grande L, Johnson M, Jacobson AF, Spain W: Antiepileptic drug-induced bone loss in young male patients who have seizures. Arch Neurol 2002;59:781–786.
69.
Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G: Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology 2002;58:1348–1353.
70.
Valimaki MJ, Tiihonen M, Laitinen K, Tahtela R, Karkkainen M, Lamberg-Allardt C, et al: Bone mineral density measured by dual-energy X-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs. J Bone Miner Res 1994;9:631–637.
71.
Sheth RD, Wesolowski CA, Jacob JC: Effect of carbamazepine and valproate on bone mineral density. J Pediatr 1995;127:256–262.
72.
Adams HPJ, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al: Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655–1711.
73.
Casele H, Haney EI, James A, Rosene-Montella K, Carson M: Bone density changes in women who receive thromboprophylaxis in pregnancy. Am J Obstet Gynecol 2006;195:1109–1113.
74.
Barbour LA, Kick SD, Steiner JF, LoVerde ME, Heddleston LN, Lear JL, et al: A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994;170:862–869.
75.
Dahlman TC, Sjoberg HE, Ringertz H: Bone mineral density during long-term prophylaxis with heparin in pregnancy. Am J Obstet Gynecol 1994;170:1315–1320.
76.
Dahlman TC: Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993;168:1265–1270.
77.
Monreal M, Lafoz E, Olive A, del Rio L, Vedia C: Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumadin. Thromb Haemost 1994;71:7–11.
78.
Pettila V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R: Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002;87:182–196.
79.
Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, et al: Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006;355:2427–2443.
80.
Yaturu S, Bryant B, Jain S: Thiazolidinediones treatment decreases bone mineral density in type 2 diabetic men. Diabetes Care 2007;30:1574–1576.
81.
Pang MY, Ashe MC, Eng JJ, McKay HA, Dawson AS: A 19-week exercise program for people with chronic stroke enhances bone geometry at the tibia: a peripheral quantitative computed tomography study. Osteoporos Int 2006;17:1615–1625.
82.
Sato Y, Maruoka H, Oizumi K: Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation. Stroke 1997;28:736–739.
83.
Sato Y, Honda Y, Kuno H, Oizumi K: Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone 1998;23:291–296.
84.
Sato Y, Asoh T, Kaji M, Oizumi K: Beneficial effect of intermittent cyclical etidronate therapy in hemiplegic patients following an acute stroke. J Bone Miner Res 2000;15:2487–2494.
85.
Sato Y, Iwamoto J, Kanoko T, Satoh K: Risedronate therapy for prevention of hip fracture after stroke in elderly women. Neurology 2005;64:811–816.
86.
Sato Y, Iwamoto J, Kanoko T, Satoh K: Risedronate sodium therapy for prevention of hip fracture in men 65 years or older after stroke. Arch Intern Med 2005;165:1743–1748.
87.
Poole KE, Loveridge N, Rose CM, Warburton EA, Reeve J: A single infusion of zoledronate prevents bone loss after stroke. Stroke 2007;38:1519–1525.
88.
Uebelhart D, Hartmann DJ, Barbezat S, Mermillod B, Chantraine A: Effect of calcitonin on bone and connective tissue metabolism in hemiplegic patients: a two-year prospective study. Clin Rehabil 1999;13:384–391.
89.
Poole KE, Reeve J, Warburton EA: Falls, fractures, and osteoporosis after stroke: time to think about protection? Stroke 2002;33:1432–1436.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.